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Chemistry and material 
science at the cell surface
The interface of chemistry, material science and biology presents 
many opportunities for developing innovative tools to answer 
fundamental biology questions and diagnose/treat various diseases. 
The past decade has witnessed an explosion in the development of 
novel materials and methods, including some on a nano-scale, which 
can be applied to fields including tissue engineering, diagnostics, 
drug delivery, and medical devices. A particularly exciting subject 
in the field is the direct engineering and manipulation of living 
cells, the basic structural and functional unit of living organisms. 
Excellent examples include controlling cell fate by biomaterial 
scaffolds1,2, labeling cells with molecular and nanoparticle probes 
for imaging and visualization of cellular processes and molecular 
pathways3-5, delivery of diverse species into cells6,7, and patterning 
cells for drug discovery8-10. This review focuses on the engineering 
of the cell surface, a fertile ground for chemists and material 
scientists to manipulate cell phenotypes and biological fates. This 
will open up new avenues for biologists to interrogate basic cellular 
functions, or advance cell-based therapies and diagnostics. The cell 
membrane is a highly heterogeneous and dynamic environment 
comprising mainly proteins, lipids, and carbohydrates, which 
mediate cell-cell and cell-niche communication and intracellular 
signaling, ultimately governing cell fate11,12. To date, cell surface 
engineering has primarily been a subject of molecular biology. 
However, tools developed by chemists and material scientists 
provide simple alternatives to the genetic and biosynthetic 
approaches. Specifically, targeting molecules, molecular and 
nanoparticle probes, polymer patches, and nanostructures can be 
introduced onto the cell surface by conjugation (covalently and 
non-covalently), or by utilizing biomolecular recognition such 
as antibody/antigen and biotin/streptavidin interactions. These 
tools greatly enhance our ability to use and manipulate cells, and 
answer biological questions. This review highlights the most recent 
developments in this field with particular focuses on the use of cell 
surface engineering strategies for
Cell surfaces are fertile ground for chemists and material scientists 
to manipulate or augment cell functions and phenotypes. This not only 
helps to answer basic biology questions but also has diagnostic and 
therapeutic applications. In this review, we summarize the most recent 
advances in the engineering of the cell surface. In particular, we focus 
on the potential applications of surface engineered cells for 1) targeting 
cells to desirable sites in cell therapy, 2) programming assembly of cells 
for tissue engineering, 3) bioimaging and sensing, and ultimately 4) 
manipulating cell biology.
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1) targeting cells to desirable sites in cell therapy, 
2) programming assembly of cells with substrates or cells in 
tissue engineering, 
3) bioimaging and sensing, and 
4) manipulating cell biology. 
Cell encapsulation, cell-matrix interactions, and the detailed 
mechanisms of chemical reactions involved in cell surface 
modification, which are subjects of several recent excellent 
reviews11,13-19, will not be discussed here.
Cell targeting
Delivery of systemically infused cells, particularly stem/progenitor 
cells, into damaged or diseased tissue holds enormous promise for 
the treatment of a variety of diseases worldwide20. For instance, 
hematopoietic stem cell (HSC) transplantation (i.e. bone marrow 
transplantation), which has been used in the clinic for several decades 
to treat blood diseases and cancer, requires systemically infused 
HSCs to home to the bone marrow from the blood. Mesenchymal 
stem cells (MSCs) are similarly believed to home to various sites of 
inflammation and injury in the body after being systemically infused. 
MSCs which are capable of differentiating into connective tissue 
cells types that can produce bone, cartilage and fat, and produce 
immunomodulatory cytokines, are currently being tested in clinical 
trials for treatment of numerous diseases including graft versus host 
disease, myocardial infarction, multiple sclerosis, and skeletal tissue 
repair, among others20. Unfortunately, systemically administered 
therapeutic cells home to the target sites at low efficiencies (typically 
< 1%), which is due to, at least in part, the lack of expression (or 
loss during culture expansion) of key homing receptors21. Therefore, 
efforts have been made to introduce cell homing ligands onto cell 
membranes. Cell homing ligands (on the homing cell) and receptors 
(on the endothelium) allow homing cells to tether, roll, adhere and 
then transmigrate on endothelium as part of the cell homing cascade. 
Methods include genetic22-24 and enzymatic engineering25, treatment 
with cytokines26 and, as will be discussed here in detail, chemical 
approaches27,28 (Fig. 1a). For instance, we have recently developed 
a simple platform technology to chemically attach cell adhesion 
molecules to MSC surface to improve homing efficiency to inflamed 
tissues27. Specifically, this chemical approach (Fig. 1b) involves a 
stepwise process including:
1) treatment of cell amine groups with sulfonated biotinyl-N-
hydroxy-succinimide (NHS) to introduce biotin groups on the cell 
surface, 
2) addition of streptavidin that binds to the biotin on the cell surface 
and presents unoccupied binding sites, and 
3) attachment of biotinylated homing ligands. In our model system, 
a biotinylated sialyl Lewis X (SLeX), a ligand that binds to P and E 
selectins expressed on the inflamed endothelium and allows cells to 
roll on the endothelial layer, was conjugated on the MSC surface. 
The SLeX modified MSCs demonstrated a robust rolling response on 
a P-selectin coated substrate under shear stress conditions in vitro27 
and on inflamed endothelium in vivo (Sarkar et al. unpublished). In 
addition, homing ligands can be introduced onto the cell membrane 
using non-covalent chemical modification28,29. In a recent work from 
Dennis and co-workers28, MSCs were treated with palmitated protein 
G where the palmitate chain was incorporated into lipid bilayer via 
hydrophobic interactions and protein G provides generic binding sites 
for antibodies (Fig. 1c). In their proof-of-concept work, intercellular cell 
adhesion molecule-1 (ICAM-1) antibodies were conjugated onto MSCs 
Fig. 1 a) Schematic showing targeting of cells from blood to inflamed endothelium 
expressing receptors that bind to ligands engineered on the cell surface. Two 
methods of engineering the homing ligand onto the cell surfaces, using covalent 
and noncovalent chemistry, are shown in b) and c), respectively. b) Stepwise 
process of attaching SLeX to MSCs using biotin-streptavidin linkers, and c) 
incorporation of palmitated protein G into the cell membrane and subsequent 
conjugation with an ICAM-1 antibody.(a) and b) reprinted with permission from27. 
©ACS 2008. c) adapted with permission from28. ©Elsevier 2009).
(b)
(a)
(c)
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which enabled the cells to bind to ICAM-1, a critical adhesion molecule 
expressed on activated endothelium. Note that these chemical 
approaches to modify the cell surface and immobilize required ligands 
are not limited to MSCs or the above-mentioned ligands. Rather they 
should have broad implications on cell therapies that utilize systemic 
administration and require targeting of cells to specific tissues. 
Presumably, if we know which receptors are present on endothelium 
in a targeted anatomical site, we could deliver cells specifically to that 
site by engineering the complementary ligands onto the cell surface.
Programmed cell-substrate and cell-cell 
assembly
The precise 3D arrangement and orientation of cells and their substrate 
(e.g. extracellular matrix), is a key criterion in cell-based assays and 
microfluidic devices as well as tissue engineering where one goal 
is to mimic the 3D complexity of native tissues30. Towards this 
end, chemists and material scientists have begun to engineer cells 
with biorecognition moieties that are not possessed by native cells 
to control cell-cell and cell-substrate interactions31,32. Francis and 
colleagues have demonstrated the use of single-stranded DNA (ssDNA) 
to mediate cell adhesion on a substrate33. In their work, ssDNA was 
attached onto cells by a Staudinger ligation reaction between azides 
(delivered to cell surface glycans via a metabolism process)34 and 
phosphine groups modified on ssDNA or by a simple NHS ester (on 
DNA) and NH2 (on cell surface) chemistry35. The ssDNAs attached on 
cells directed the assembly of cells on complementary DNA-attached 
substrate via DNA hybridization (Fig. 2). Such DNA-modified cells can 
also be assembled, on a single cell level, on microfabricated patterned 
sensor devices that may be used for single cell analyses, such as 
measuring cellular electrical and metabolic activation. In a more recent 
work from Mathies and co-workers36, an array of lithographically 
patterned iridium oxide pH microelectrodes was enclosed within 
a microfluidic channel on which ssDNA was attached using silane 
chemistry. Such devices could then capture complementary DNA-
modified cells and measure the single cell metabolism using pH as an 
indicator. They demonstrated that such devices are able to discriminate 
between healthy primary T cells and cancerous Jurkat T cells that have 
a higher metabolism. 
Fig. 2 DNA sequence-specific capture cells on substrate. a) General scheme of experiment where blue and green dye-labeled Jurkat cell populations were functionalized 
with DNA sequence A or B, respectively. An equal number of cells were combined and the mixture was introduced into a microfluidic device with DNA sequence bound to 
one surface. Only cells with complementary DNA sequences should bind postwash. b) Fluorescence images of 1) the cell mixture prewash; 2) an A’-coated pad postwash; 
3) a B’-coated pad postwash.  (Reprinted with permission from33. ©Wiley-VCH Verlag GmbH & Co. KGaA 2006).
(b)
(a)
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The DNA-based approach can also be used for the programmable 
assembly of 3-D cell structures, which may find applications in 
synthesizing artificial tissues37,38. Recently, Gartner and Bertozzi 
elegantly demonstrated that DNA-modified cells can be assembled into 
microtissues in a well-defined manner (i.e. structures were controlled 
by varying the DNA site density on the cell surface, cell concentration, 
and DNA sequence)38. Briefly, by adjusting the stoichiometry (i.e. 
1:50) of two Jurkat cell population modified with complementary DNA 
strands, single cell clusters were produced where the limiting cell type 
was surrounded by cells added in excess (Fig. 3a,b). Interestingly, using 
fluorescent labeled DNA, they showed that DNA strands are clustered 
at the cell-cell interface (Fig. 3c), confirming their specific role in 
cell-cell assembly. Significantly, such assembled cell clusters could be 
isolated and purified using flow cytometry, and subsequently used as 
the core for further iterative cell assembly, i.e. adding another layer of 
DNA-modified cells (Fig. 3d-f). More importantly, they demonstrated 
that cells within the assembled microtissues communicated via a 
paracrine mechanism, which is a prerequisite for the development 
of therapeutically functional tissues. Specifically, in their proof-of-
concept model, a CHO cell line engineered to express growth factor 
interleukin-3 (IL-3) was used as a first building block and the second 
was an untransformed hematopoietic progenitor cell line (FL5.12) 
whose survival and replication depends on the presence of IL-3. Cell 
composites were assembled using the above-mentioned DNA approach 
and then embedded within a 3-dimensional agarose matrix. After 
16 h, the cell structures underwent accelerated growth due to the 
presence of IL-3. By contrast, when CHO cells lacking the gene coding 
in IL-3 were used in the microtissue, FL5.12 cells showed no growth 
and instead underwent a morphological change corresponding to the 
absence of IL-3 induced apoptosis. Finally, other advantages of using 
DNA assembly in such systems include their reversibility and versatility 
with respect to engineering multiple orthogonal cell-cell interactions. 
In addition to ssDNA, self-assembled cargo-carrying DNA arrays (Fig. 
4) can also be attached onto the cell surface (Fig. 5a). Reich and 
colleagues attached hexagonal DNA arrays on cells using streptavidin 
and antibody as bridges39. In their study, it was observed that one or 
two DNA array patches often attached to one cell, and that single DNA 
arrays often bridged cells (Fig. 5c-e). Occasionally, micron-sized DNA 
Fig. 3 a) General scheme of multilayered cell assembly using DNA hybridization. (b)Schematic of DNA hybridization between 2 cells (shown in red and green) c) 
Fluorescence image of a cluster of assembled cells (blue) with intercellular DNA linkages (green). Clustering of DNA crosslinkers cellular interface can be observed. 
d) Gating of assembled cells in fluorescence activated flow cytometry. e) Fluorescence image showing assembled cells isolated by flow cytometry.  f) Fluorescence 
image of an assembled cell cluster from (e) which underwent a second assembly step to acquire another layer of cells. All scale bars are 10μm. (Reprinted with 
permission from38. ©PNAS 2009).
(b)
(a)
(c)
(d) (e) (f)
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arrays seemed capable of binding to and enveloping multiple cells into 
larger cellular structures (Fig. 5b). These larger structures may have 
the potential to form the foundation for the construction of tissues or 
organs for transplantation in tissue engineering. 
  Engineered cell-cell interactions in a bottom-up tissue 
engineering approach can also be achieved by attaching cell-
adhesive polyelectrolyte patches on the cell surface. Swiston et al. 
recently used a photolithographic-pattering technique to engineer 
multilayer polymer patches containing a payload component (i.e. 
super-paramagnetic nanoparticles) onto T cell surfaces (Fig. 6)40. The 
magnetic nanoparticles allowed cells to be spatially manipulated using 
an external magnetic field. Importantly, patch-functionalized cells could 
be programmed to assemble into sheet, rings, or cluster structures.  
Patches that are cell-adhesive may allow the polymerization of 
Fig. 5 (a) Image of fluorescent DNA hexagonal arrays on HeLa cells, acquired by confocal microscopy. DNA arrays are green and HeLa cell surfaces red; HeLa 
cytoplasm is blue (50 μm scale bar). (b) Image of a large DNA array binding and enveloping multiple HeLa cells, acquired by confocal microscopy. DNA arrays 
are green and HeLa cell surfaces red; HeLa cytoplasm is blue (50 μm scale bar). (c-e) Fluorescent DNA arrays bound to HeLa cells visualized in DIC mode 
(10 μm scale bar). (Reprinted with permission from39. ©ACS 2009).
Fig. 4 Assembly of fluorescent DNA hexagonal arrays. (a) Diagram of the biotinylated three-point-star monomer used to form the DNA arrays. (b) Diagram of an 
18 unit biotinylated hexagonal DNA array (30 nm scale bar). (c) AFM image of a biotinylated hexagonal DNA array (100 nm scale bar). (d) Biotinylated hexagonal 
DNA arrays labeled with YOYO 1 DNA staining dye on a mica surface (10 μm scale bar). (Reprinted with permission from39. ©ACS 2009).
(b)(a)
(c) (d)
(b)(a)
(c) (d) (e)
MT1304p14_21.indd   18 12/03/2010   14:57:29
Chemistry and material science at the cell surface   REVIEW 
APRIL 2010  |  VOLUME 13  |  NUMBER 4 19
cellular species, with individual cells being the monomers and the 
patches serving as bifunctional linkages (Fig. 7), for construction of 
macroscopic, functional tissues.
Bioimaging and sensing 
One particularly important application of cell surface engineering 
is to introduce sensing and imaging probes to visualize cellular and 
molecular events both in cells and living organisms. The Bertozzi 
group at University of California, Berkerley, has pioneered the use of 
chemical reporters for such purposes with a focus on those that can 
be incorporated through metabolic pathways. Such systems have been 
summarized recently by the same group in several excellent reviews 
which we refer to interested readers11,16-19,41.
An example of their technology is the engineering of chromatic 
polydiacetylene (PDA) polymer patches onto cell surfaces for 
imaging structural perturbations of the membrane bilayer42. 
Specifically, vesicles comprising of diacetylene and lipid molecules 
including 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine 
and 1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] were 
first formed in solution. These lipid vesicles were then fused with 
cell membrane and PDA was formed in situ upon UV-mediated 
polymerization. The conjugated PDA nanopatches on cells exhibited 
an intense blue color (Fig. 8a, left tube) and underwent a blue-to-
red color change (Fig. 8a, right tube) upon structural perturbations 
of the cell membrane due to conformational transitions in the 
conjugated (ene–yne) polymer backbone. During this blue-to-
red color transition, the initial non-fluorescent PDA also emitted 
fluorescence at 560 nm and 640 nm (Fig. 8b,c). The PDA nanopatches 
can therefore be used to visualize the cell bilayer perturbations induced 
by, for example, lidocaine, polymyxin-B, cholesterol, and oleic acid, and 
to screen toxic pesticides and other environmentally sensitive small 
molecules43. 
Fig. 6 Overview of a cell functionalization scheme, using cell-adhesive 
polyelectrolyte patches. In this particular example, cell adhesive region, 
payload region and release region are chitosan-hyaluronic acid, FITC-
poly(allylamine hydrochloride), poly(methylacrylic acid)-poly(N-
isopropylacrylamide), respectively. (a) A regular array of surface-bound 
patches spaced 50 μm apart. Payload regions are labeled green. After cell 
incubation and attachment (b), a majority (85 ± 3%) of the surface bound 
patches are occupied. Cell cytoplasm is labeled red. (c) After the temperature 
is reduced to 4°C for 30 min, the patches are released from the surface while 
remaining attached to the cell membrane. All scale bars are 25 μm. (Reprinted 
with permission from40. ©ACS 2008).
Fig. 7 An overlay of fluorescence microscopy images demonstrating different degrees of cell aggregation mediated by polymer patches. Cells and polymer patches 
are labeled in red and green, respectively. Scale bar is 10 μm. (Reprinted with permission from40. ©ACS 2008).
(a)
(b)
(c)
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Manipulating cell biological fate
One ultimate goal of engineering the cell surface is to use externally 
applied chemical moieties and materials to control cell biology. As 
an initial effort, Ingber and co-workers have demonstrated the use 
of magnetic nanoparticles on cell membrane to regulate cellular 
signaling pathways44. Specifically, mast cells express membrane FcεRI 
receptors that can bind to the Fc region of IgE molecules (Fig. 9a). 
Multivalent antigens (dinitrophenyl, DNP) that bind to IgE can then 
induce FcεRI receptor oligomerization on cell membrane whereas 
monovalent antigens do not. The FcεRI receptor clustering quickly 
triggers an intracellular signaling response characterized by a rapid 
rise of cytosolic Ca2+, which in turn leads to the local inflammatory 
response of mast cells. Instead of using antigens to induce the above 
mentioned pathway, Ingber and colleagues immobilized DNP-attached 
magnetic nanoparticles45 on IgE-tethered mast cells44 (Fig. 9a). They 
ensured that only one DNP molecule was attached on each particle so 
that receptor clustering did not occur. When an external magnetic field 
was applied, magnetic nanoparticles clustered by themselves on the 
cell membrane, which caused the oligomerization of FcεRI receptors, 
a process which could be visualized by the local Ca2+ concentration 
change (Fig. 9b,c). Significantly, such magnetic nanoparticle mediated 
cellular signaling is reversible: switching on and off the magnetic field 
directly corresponds to a local Ca2+ concentration oscillation (Fig. 9d). 
Conclusion and perspectives
While promising, cell surface engineering research is still in its infancy 
and many issues remain to be addressed. One technical challenge is 
adapting chemical modification methods to suit the highly dynamic 
and heterogeneous environment of the cell. For instance, when 
chemical and material moieties are introduced on the cell surface, one 
has to consider the following factors: site density, distribution, mobility, 
and stability (shedding or internalization) that may be critical for 
down-stream applications.  Furthermore, the newly introduced moieties 
on the cell surface should be accessible for the relevant application 
(e.g. binding to receptors on other cells), and not hindered by steric 
effects27 brought about by conformational change or the presence of 
other cell surface proteins.
It is important to consider and assess how cell surface modifications 
and introduction of external materials impact the cell’s phenotype. 
Most of the above-mentioned examples have characterized the 
impact of cell surface modification on cell viability but more detailed 
characterization is required. We studied the impact of SLeX modification 
on MSCs’ native functions including adhesion, proliferation, viability, 
differentiation, and in vivo transendothelial migration27. Rubner et al. 
studied the influence of cell membrane-attached polymer patches 
on T cell viability and migration40. Overall, it appears possible to 
modify cell membranes with specific ligands, micron sized patches, 
and nanoparticles46, without significantly altering cell phenotype. 
Nevertheless, more detailed analysis is required including examination 
of how specific modifications may impact gene expression profiles.
During the past decade, chemists and materials scientists have 
joined biologists to physically and chemically manipulate and engineer 
cell membranes for a variety of applications. Desirable chemical 
functionalities and materials can be introduced onto the cell surface 
by covalent and noncovalent chemistry as well through specific 
biological recognition events including antibody/antigen or ligand/
receptor interactions. Cell surface engineering represents a powerful 
new approach that will likely find broad utilities in tissue engineering, 
cell therapy, cell-based assays and devices, drug delivery and discovery, 
biosensing/bioimaging, cell separation, and manipulation of cell 
biological fate.  
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Fig. 8 a) Photographs of tubes containing PDA-labeled cells after 
sedimentation. Left tube: blue cells before treatment; right tube: cells after 
incubation with oleic acid (180 μM), b) and c) are confocal microscopy 
fluorescence images (left) and transmission differential interference contrast 
(DIC) microscopy images (right) of PDA-labeled U937 cells. b) and c) show 
cells before and after polymyxin-B (50 μM) treatment, respectively. Scale 
bars in all images correspond to 10 μm.  (Reprinted with permission from42. 
©Wiley-VCH Verlag GmbH & Co. KGaA 2005).
(b)
(a)
(c)
MT1304p14_21.indd   20 12/03/2010   14:57:40
Chemistry and material science at the cell surface   REVIEW 
APRIL 2010  |  VOLUME 13  |  NUMBER 4 21
REFERENCES
1. Huebsch, N., and Mooney, D. J., Nature (2009) 462 (7272), 426.
2. Zhao, W., and Karp, J. M., ChemBioChem (2009) 10 (14), 2308.
3. Anker, J. N., et al., Nat. Mater. (2008) 7 (6), 442.
4. Zhao, W., and Karp, J. M., Nat. Mater. (2009) 8 (6), 453.
5. Giepmans, B. N. G., et al., Science (2006) 312 (5771), 217.
6. Schmidt, U., et al., FASEB J. (2001) 15 (9), 1646.
7. Akin, D., et al., Nature Nanotech. (2007) 2 (7), 441.
8. Chen, S., and Smith, L. M., Langmuir (2009) 25 (20), 12275.
9. Kang, L., et al., J. Biomed. Mater. Res., Part A (2009), doi: 10.1002/jbm.a.32557 
(Article online in advance of print).
10. Falconnet, D., et al., Biomaterials (2006) 27 (16), 3044.
11. Mahal, L. K., and Bertozzi, C. R., Chemistry & Biology (1997) 4 (6), 415.
12. Kellam, B., et al., Chem. Soc. Rev. (2003) 32, 327.
13. Orive, G., et al., Biomaterials (2006) 27 (20), 3691.
14. Beck, J., et al., Tissue Eng. (2007) 13 (3), 589.
15. Stevens, M. M., and George, J. H., Science (2005) 310 (5751), 1135.
16. Cook, B. N., and Bertozzi, C. R., Bioorg. Med. Chem. (2002) 10 (4), 829.
17. Hang, H. C., and Bertozzi, C. R., Acc. Chem. Res. (2001) 34 (9), 727.
18. Laughlin, S. T., and Bertozzi, C. R., Proc. Nat. Acad. Sci. USA. (2009) 106 (1), 12.
19. Agard, N. J., and Bertozzi, C. R., Acc. Chem. Res. (2009) 42 (6), 788.
20. Karp, J. M., and Teo, G. S. L., Cell Stem Cell (2009) 4 (3), 206.
21. Rombouts, W. J. C., and Ploemacher, R. E., Leukemia (2003) 17 (1), 160.
22. Kumar, S., et al., Gene Ther. (2010) 17, 105.
23. Brenner, S., et al. Stem Cells (2004) 22 (7), 1128.
24. Zhang, D., et al., J. Mol. Cell. Cardiol. (2008) 44 (2), 281.
25. Sackstein, R., et al., Nat. Med. (2008) 14 (2), 181.
26. Chavakis, E., et al., J. Mol. Cell. Cardiol. (2008) 45 (4), 514.
27. Sarkar, D., et al., Bioconjugate Chem. (2008) 19 (11), 2105.
28. Ko, I. K., et al., Biomaterials (2009) 30 (22), 3702.
29. Rabuka, D., et al., J. Am. Chem. Soc. (2008) 130 (18), 5947.
30. Khademhosseini, A., et al., Scientific American (2009) 300, 64.
31. Borisenko, G. G., et al., Nucleic Acids Res. (2009) 37 (4), e28.
32. Kamitani, R., et al., ChemBioChem (2009) 10 (2), 230.
33. Chandra, R. A., et al., Angew. Chem. Int. Ed. (2006) 45 (6), 896.
34. Prescher, J. A., et al., Nature (2004) 430 (7002), 873.
35. Hsiao, S. C., et al., Langmuir (2009) 25 (12), 6985.
36. Douglas, E. S., et al., Lab Chip (2009) 9 (14), 2010.
37. Paul, A. D. B., et al., Biotechnol. Bioeng. (2007) 97 (6), 1617.
38. Gartner, Z. J., and Bertozzi, C.R., Proc. Nat. Acad. Sci. USA. (2009) 106 (12), 4606.
39. Koyfman, A. Y., et al., J. Am. Chem. Soc. (2009) 131 (40), 14237.
40. Swiston, A. J., et al., Nano Lett. (2008) 8 (12), 4446.
41. Prescher, J. A., and Bertozzi, C. R., Nat. Chem. Biol. (2005) 1 (1), 13.
42. Orynbayeva, Z., et al., Angew. Chem. Int. Ed. (2005) 44 (7), 1092.
43. Mech, A., et al., Chem. Res. Toxicol. (2009) 22 (1), 90.
44. Mannix, R. J., et al., Nature Nanotech. (2008) 3 (1), 36.
45. Yung, C. W., et al., Lab Chip (2009) 9 (9), 1171.
46. Cheng, H., et al., ACS Nano (in press), doi: 10.1021/nn901319y
Fig. 9 Nanomagnetic control of receptor signal transduction. a) The biochemical mechanism that stimulates downstream signalling (left) involves the binding of 
multi-valent ligands (represented by green hexagons) that induce oligomerization of individual IgE/ FcεRI receptor complexes. In the magnetic switch, monovalent 
ligand-coated magnetic nanobeads (dark grey circles), similar in size to individual FcεRI receptors, bind individual IgE/ FcεRI receptor complexes without inducing 
receptor clustering (centre). However, applying a magnetic field that magnetizes the beads and pulls them into tight clusters (right) rapidly switches on receptor 
oligomerization and calcium signalling. b) The pseudocoloured microfluorimetric image shows the local induction of calcium signaling (yellow) in cells near the tip 
of the electromagnet within 20 s of the field  being applied. Scale bar is 50 μm. c) Quantification of peak changes in intracellular calcium relative to time 0 measured 
within individual cells during a 1-min pulse of applied magnetic force as a function of the distance of the tip from the cell surface. d) Effect of a rapid cyclical 
magnetic stimulation regimen (40 s on, 20 s off) on intracellular calcium signaling. (Reprinted with permission from44. ©NPG 2008).
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